About Us

We are accelerating transformative therapies for kids with cancer and rare diseases.

Launched in 2025, CobiCure Therapeutics is committed to accelerating the development of urgently needed therapies for children with cancer and rare diseases.

Through our collaborative drug development accelerator, we are building a pipeline of transformative medicines that might otherwise go undeveloped for financial reasons. By bridging the gap between scientific innovation and unmet medical needs, CobiCure Therapeutics is redefining what is possible in pediatric and rare disease treatment.

Our Business Model

CobiCure Therapeutics focuses on sourcing and advancing promising therapies through strategic acquisition, development and collaboration.

In-licensing, acquiring, or co-developing promising therapeutic assets with the potential to reduce childhood morbidity and mortality

Accelerating development from research through clinical trials and regulatory milestones, with a focus on streamlined fixed costs, urgency, and fastest path to market

Partnering with world-class scientists, clinicians, funders, and advocates to combine top-tier expertise with mission alignment

Building and sustaining a portfolio of future cures

Our Team

We are a visionary team with deep expertise in healthcare investment, drug development, clinical research, scientific innovation, and philanthropy. We are united by a shared mission to eliminate barriers in healthcare and advance therapies for children and patients with rare diseases.

Mark Veich

Chief Executive Officer

Michele Cleary

President and Chief Scientific Officer

Robert Olan

Vice President, Business Development

Schuyler Kennedy

Associate Director, Business Development and Operations

Maureen Reyes

Director, Strategy and Operations

Lindsey Reynolds

Director, Finance and Operations

Jyoti Patel

Director, Marketing and Operations

We’re Part of Something Bigger

Advancium Health Network is a mission-driven public charity pioneering ways to overcome barriers in healthcare through a unique model that combines for-profit infrastructure with non-profit ideals. Advancium forges bonds between a diverse body of industry partners, experts, and philanthropic support to leverage its collective expertise and resources toward developing pediatric medical devices and drug therapies. We are confronting healthcare’s most daunting hurdles for underserved patients and catalyzing a positive impact on human health.

Visit Advancium Health